255 related articles for article (PubMed ID: 15222613)
1. [Influence of recent trials on essential arterial hypertension management].
Rossignol P; Le Coz S; Plouin PF
Rev Prat; 2004 Mar; 54(6):626-32. PubMed ID: 15222613
[TBL] [Abstract][Full Text] [Related]
2. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria.
Cuspidi C; Meani S; Salerno M; Severgnini B; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
Blood Press; 2004; 13(3):144-51. PubMed ID: 15223722
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
[TBL] [Abstract][Full Text] [Related]
6. [Antihypertensive therapy according to the ESH/ESC guidelines].
Waeber B; Feihl F
Rev Med Suisse; 2007 Sep; 3(124):2003-4, 2006. PubMed ID: 17955827
[TBL] [Abstract][Full Text] [Related]
7. Lessons from ALLHAT. Are low budget diuretics first line therapy in hypertension?
Unger T
Z Kardiol; 2004 May; 93(5):349-56. PubMed ID: 15160270
[TBL] [Abstract][Full Text] [Related]
8. [Hypertension management in general practice in Iceland].
Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
[TBL] [Abstract][Full Text] [Related]
9. [French as 2005-recommendations on the management of arterial hypertension].
Chamontin B; Halimi JM
Arch Mal Coeur Vaiss; 2007 Jan; 100(1):42-6. PubMed ID: 17405553
[TBL] [Abstract][Full Text] [Related]
10. Choice of antihypertensive drug in the diabetic patient.
Ong HT; Cheah JS
MedGenMed; 2005 May; 7(2):74. PubMed ID: 16369452
[TBL] [Abstract][Full Text] [Related]
11. Which drug should be used to treat patients with uncomplicated essential hypertension?
Rashidi A; Rahman M; Wright JT
Curr Opin Nephrol Hypertens; 2006 May; 15(3):303-8. PubMed ID: 16609299
[TBL] [Abstract][Full Text] [Related]
12. [Recently published European and American guidelines for the diagnosis and treatment of hypertension].
van Zwieten PA; Struijker Boudier HA; de Leeuw PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):868-71. PubMed ID: 15152386
[TBL] [Abstract][Full Text] [Related]
13. Current possibilities of ACE inhibitor and ARB combination in arterial hypertension and its complications.
Kolasinska-Malkowska K; Filipiak KJ; Gwizdala A; Tykarski A
Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):759-71. PubMed ID: 18510491
[TBL] [Abstract][Full Text] [Related]
14. [New tendencies in combination antihypertensive therapy].
van der Giet M; Paul M
MMW Fortschr Med; 2005 Nov; 147(46):44-6. PubMed ID: 16358634
[TBL] [Abstract][Full Text] [Related]
15. [Evidence-based usefulness of Ca antagonists and ACEIs and ARBs for the primary and secondary prevention of major cardiovascular and renal events in patients with hypertension].
Fujino T; Hasebe N; Kikuchi K
Clin Calcium; 2005 Oct; 15(10):1695-708. PubMed ID: 16199917
[TBL] [Abstract][Full Text] [Related]
16. Complications of hypertension and the role of angiotensin receptor blockers in hypertension trials.
Flaa A; Aksnes TA; Strand A; Kjeldsen SE
Expert Rev Cardiovasc Ther; 2007 May; 5(3):451-61. PubMed ID: 17489670
[TBL] [Abstract][Full Text] [Related]
17. ALLHAT in perspective: implications to clinical practice and clinical trials.
Yusoff K
Med J Malaysia; 2005 Jun; 60(2):239-45. PubMed ID: 16114170
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of target organ damage caused by hypertension: therapeutic potential.
Cohuet G; Struijker-Boudier H
Pharmacol Ther; 2006 Jul; 111(1):81-98. PubMed ID: 16288809
[TBL] [Abstract][Full Text] [Related]
19. [Should we modify our therapeutic behavior as a consequence of the 2009 revision of the ESH/ESC guidelines for the management of arterial hypertension].
Calderón A; Escobar C; Barrios V
Rev Clin Esp; 2010 Nov; 210(10):511-6. PubMed ID: 20850113
[TBL] [Abstract][Full Text] [Related]
20. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
Khan NA; McAlister FA; Lewanczuk RZ; Touyz RM; Padwal R; Rabkin SW; Leiter LA; Lebel M; Herbert C; Schiffrin EL; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; DeChamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Campbell NR; Arnold M; Moe G; Hill MD; Jones C; Larochelle P; Ogilvie RI; Tobe S; Houlden R; Burgess E; Feldman RD;
Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
